Alderley Park Science Seminar: AI in Drug Discovery
Join Professor John Overington, our CIO, for an exclusive insight into applying AI and machine learning to drug discovery.
John has over 30 years experience of drug discovery informatics, across academic, biotech and large pharma sectors. He has deep experience of the application of informatics methods to problems in drug discovery, ranging from target selection through to real world evidence analytics of drug patient benefits. His current professional interests focus on big data, machine learning and artificial intelligence.
